Fri, 11 Sep 2026

Multicare automates data consolidation with Qlik

pexels-brett-sayles-2881229 data center

Multicare Pharmaceutical Philippines Inc., one of the country’s fastest-growing pharmaceutical companies, has deployed Qlik Cloud Analytics to modernise data consolidation, enabling better access to insights, decision-making, and operational management nationwide.

Julie Ann Catalan
Julie Ann Catalan

ā€œOur teams need fast, reliable insights to make decisions in real time – especially when operating across multiple regions, partners, and channels,ā€ said Julie Ann Catalan, commercial excellence manager, Multicare Pharmaceutical Philippines Inc.

ā€œQlik has significantly reduced the time it takes us to access and analyse data, improved efficiency across our processes, and lowered our reliance on manual reporting. This allows our teams to respond with greater confidence and precision, wherever they are,ā€ Catalan said.

Automating data consolidation

Automating data consolidation with Qlik led Multicare to an estimated 20% savings in data support and service expenses, along with significant time savings.

Over 200 field staff and 30 sales leaders can now securely access up-to-date analytics through Qlik’s mobile-ready dashboards, transforming access to insights across the organisation.

Working alongside Qlik partner Micropinnacle Technology Corporation (MTC), Multicare deployed Qlik Sense to deliver portable, self-service analytics that support decision-making.

Maurizio Garavello
Maurizio Garavello

ā€œHealthcare and pharmaceutical organisations are under constant pressure to operate efficiently while managing complex, distributed operations,ā€ said Maurizio Garavello, senior vice president, APAC, Qlik. ā€œBy enabling faster access to trusted insights and putting analytics directly into the hands of users, Qlik is helping Multicare strengthen day-to-day decision-making across its nationwide operations, without adding operational overhead.ā€

Related:  AI fluency will become baseline skill, but employees shouldn’t treat it as tool

Related Stories

MORE STORIES

Subscribe